Jan 16 |
Top 4 Health Care Stocks That May Rocket Higher In Q1
|
Jan 11 |
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
|
Jan 10 |
Vyne reports positive data from Phase 1b study for vitiligo drug
|
Jan 10 |
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
|
Jan 3 |
VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors
|
Nov 20 |
VYNE Therapeutics says director Lepore buys 13K shares in co
|
Nov 13 |
VYNE Therapeutics files to sell 36.27M shares for holders
|
Nov 13 |
VYNE Therapeutics GAAP EPS of -$2.01, revenue of $0.1M
|
Nov 13 |
VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
|
Nov 7 |
VYNE Therapeutics to Host Virtual R&D Day Event on November 9, 2023
|